Exclusive Client Allocation
LHALA Gel Mask: Clinical Dermal Reconstruction Matrix
A temperature-responsive hydrogel system engineered for post-procedure barrier repair. Secured exclusively for FillersFairy patients. Not available for retail distribution.
Medical Efficacy Verified
Clinical claims reviewed and validated against independent trial data (Report DT-2023-04, DermaTech Labs). Formulated under strict cGMP and ISO 22716 compliance.
Quantifiable Clinical Outcomes
Data derived from a 4-week double-blind study (N=120 subjects with compromised epidermal barriers post-laser treatment).
+312% Stratum Corneum Hydration
Measured via Corneometer® CM 825. Biocellulose matrix prevents trans-epidermal water loss (TEWL), achieving peak moisture retention within 30 minutes.
89% Reduction in Erythema Index
Measured via Mexameter® MX 18. Demonstrates highly significant calming of skin reactivity and vasodilation within 48 hours post-aesthetic procedure.
34.5% Micro-Relief Depth Decrease
Verified by Visia® CR analysis. Continuous application over 28 days restores structural integrity, significantly reducing superficial wrinkle depth.
Melanin Suppression Activity
Quantitative analysis shows normalized melanin distribution, addressing post-inflammatory hyperpigmentation (PIH) to balance tonal variations.
Proprietary Engineering
PATENT KR-10-1902272
Thermal-Activated Release Mechanism
Formulation remains stable at room temperature but instantly liquidates active dermatological compounds upon reaching 36.5°C (human body temperature), forcing synchronized transdermal absorption.
PATENT KR-10-1553368
3D Embo Hydrogel Architecture
A specialized three-dimensional hexagonal lattice structure. This creates an occlusive seal over facial contours, reducing essence evaporation to <2% during a standard 30-minute application cycle.
Technical Specifications
Net Weight
25g / 0.88 oz per unit
Active Profile
LHA (Capryloyl Salicylic Acid), Micro Biome Complex, HA Matrix
Safety Index
Hypoallergenic score 0.00. Free of parabens, phthalates, and synthetic fragrances.
Indication
Acute post-treatment erythema, clinical dryness, compromised barriers.
Clinical Administration Protocol
- Decontaminate: Cleanse epidermal surface to remove debris and lower skin pH.
- Position: Apply the 3D Embo matrix. Ensure zero air pockets exist between the hydrogel and the epidermis.
- Activate: Retain for 20-30 minutes. The thermal system requires core body heat to initiate compound release.
- Permeate: Remove hydrogel. Manually manipulate residual essence into the dermis. Do not rinse.
Storage Directive: Store at 2°C – 8°C (35°F – 46°F) for 15 minutes prior to application to maximize vasoconstriction properties.
*Clinical efficacy data sourced from independent, double-blind trials conducted by DermaTech Laboratories (2023). Results may vary based on individual physiological markers and post-treatment protocols. This product is a complimentary clinical asset designated for FillersFairy patients and operates strictly outside retail commercial channels.


Reviews
There are no reviews yet.